N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium

C46H42F7N17O9OsS5-2 — CID 166091706

About N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium

N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium (PubChem CID 166091706) has the molecular formula C46H42F7N17O9OsS5-2 and a molecular weight of 1460.50 g/mol. Its IUPAC name is N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium.

Molecular Properties

• Compound Name: N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium
• PubChem CID: 166091706
• Molecular Formula: C46H42F7N17O9OsS5-2
• Molecular Weight: 1460.50 g/mol
• Exact Mass: 1461.15
• IUPAC Name: N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium
• SMILES: Fc1ccc2nc([N-]Cc3ncc(-c4nnc(C(F)F)o4)s3)cn2c1.O=[Os].[CH2-]CCn1cc(N(Cc2ncc(-c3nnc(C(F)F)o3)s2)S(=O)(=O)CCCOCc2ccc(N(Cc3ncc(-c4nnc(C(F)F)o4)s3)S(=O)(=O)CC)cn2)nc1C
• InChI: InChI=1S/C32H34F4N11O7S4.C14H8F3N6OS.O.Os/c1-4-9-45-15-24(40-19(45)3)47(17-26-39-14-23(56-26)30-42-44-32(54-30)28(35)36)58(50,51)11-6-10-52-18-20-7-8-21(12-37-20)46(57(48,49)5-2)16-25-38-13-22(55-25)29-41-43-31(53-29)27(33)34;15-7-1-2-10-20-9(6-23(10)5-7)18-4-11-19-3-8(25-11)13-21-22-14(24-13)12(16)17;;/h7-8,12-15,27-28H,1,4-6,9-11,16-18H2,2-3H3;1-3,5-6,12H,4H2;;/q2*-1
• InChIKey: BVCUZBKJTRPNQR-UHFFFAOYSA-N
• XLogP: 10.00
• TPSA: 318.60 Ų
• H-Bond Acceptors: 26
• Rotatable Bonds: 26
• Heavy Atoms: 85
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	1460.50
LogP ≤ 5	10.00
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	26

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium?

The IUPAC name of N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium (CID 166091706) is N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium.

What is the SMILES notation for N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium?

The canonical SMILES for N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium is Fc1ccc2nc([N-]Cc3ncc(-c4nnc(C(F)F)o4)s3)cn2c1.O=[Os].[CH2-]CCn1cc(N(Cc2ncc(-c3nnc(C(F)F)o3)s2)S(=O)(=O)CCCOCc2ccc(N(Cc3ncc(-c4nnc(C(F)F)o4)s3)S(=O)(=O)CC)cn2)nc1C.

What is the InChIKey of N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium?

The InChIKey is BVCUZBKJTRPNQR-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H34F4N11O7S4.C14H8F3N6OS.O.Os/c1-4-9-45-15-24(40-19(45)3)47(17-26-39-14-23(56-26)30-42-44-32(54-30)28(35)36)58(50,51)11-6-10-52-18-20-7-8-21(12-37-20)46(57(48,49)5-2)16-25-38-13-22(55-25)29-41-43-31(53-29)27(33)34;15-7-1-2-10-20-9(6-23(10)5-7)18-4-11-19-3-8(25-11)13-21-22-14(24-13)12(16)17;;/h7-8,12-15,27-28H,1,4-6,9-11,16-18H2,2-3H3;1-3,5-6,12H,4H2;;/q2*-1;;.

What are the key properties of N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium?

N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium has a molecular weight of 1460.50 g/mol, XLogP of 10.00, 26 rotatable bonds, 0 hydrogen bond donors, and 26 hydrogen bond acceptors.

Where does this data come from?

All data for N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-[[5-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-ethylsulfonylamino]-2-pyridinyl]methoxy]-N-(2-methyl-1-propylimidazol-4-yl)propane-1-sulfonamide;[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazol-2-yl]methyl-(6-fluoroimidazo[1,2-a]pyridin-2-yl)azanide;oxoosmium is sourced from PubChem (CID 166091706), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).